Completed
Rasburicase for Hyperuricemia
NCT00290992
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hyperuricemia, +11 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT00080405
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
Not specified
NCT00850265
- Conditions
- Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Hospital General de Requena Requena-Valencia, Valencia, Spain
NCT00111319
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigative Clinical Research of Indiana, LLC Indianapolis, Indiana, United States
NCT00869284
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Emmanuel Gyan Tours, France
NCT00866203
- Conditions
- Hemic and Lymphatic Diseases, High-Grade Lymphomas, Immune System Diseases, +7 more
- Locations
-
- GISL Trial Office Modena, Italy
NCT00452257
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Duarte, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States
NCT00043368
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- Pfizer Investigational Site Berkely, California, United States
- Pfizer Investigational Site Gilroy, California, United States
- Pfizer Investigational Site Hollister, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00713882
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkins Disease, +9 more
- Locations
-
- Weill Cornell Medical College New York, United States
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Istituto di Ematologia e Oncologia Medica Seràgnoli Bologna, BO, Italy